Literature DB >> 18283586

High body mass index is associated with increased risk of implant dislocation following primary total hip replacement: 2,106 patients followed for up to 8 years.

Omid Sadr Azodi1, Johanna Adami, David Lindström, Karl O Eriksson, Andreas Wladis, Rino Bellocco.   

Abstract

BACKGROUND AND
PURPOSE: Implant dislocation is one of the commonest complications following primary total hip replacement (THR). We investigated the effect of body mass index (BMI) and tobacco use on the risk of this complication. SUBJECTS AND METHODS: Through linkage between the Swedish Construction Workers' cohort and the Swedish Inpatient Register, 2,106 male patients who had undergone primary THR between 1997 and 2004 were identified. We used Cox multivariable regression analysis to study the association between BMI and tobacco use and the risk of implant dislocation.
RESULTS: 53 patients (2.5%) developed implant dislocation during a mean of 2 (0-3) years of follow-up. We found overweight and obesity to be associated with increased risk of implant dislocation (HR = 2.5,95% CI: 1.1-5.5 and HR = 3.7, 95% CI: 1.5-9.3, respectively as compared to those of normal weight). There was no statistically significant association between tobacco use and the risk of dislocation.
INTERPRETATION: Greater attention should be given to high BMI as a risk factor for implant dislocation following THR.

Entities:  

Mesh:

Year:  2008        PMID: 18283586     DOI: 10.1080/17453670710014897

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  37 in total

Review 1.  Smoking and outcomes after knee and hip arthroplasty: a systematic review.

Authors:  Jasvinder A Singh
Journal:  J Rheumatol       Date:  2011-06-01       Impact factor: 4.666

Review 2.  Impingement and dislocation in total hip arthroplasty: mechanisms and consequences.

Authors:  Thomas D Brown; Jacob M Elkins; Douglas R Pedersen; John J Callaghan
Journal:  Iowa Orthop J       Date:  2014

Review 3.  The evolution of outcomes and indications for the dual-mobility cup: a systematic review.

Authors:  Cécile Batailler; Camdon Fary; Régis Verdier; Thierry Aslanian; Jacques Caton; Sebastien Lustig
Journal:  Int Orthop       Date:  2016-12-21       Impact factor: 3.075

Review 4.  Do patients lose weight after joint arthroplasty surgery? A systematic review.

Authors:  Maria C S Inacio; Donna Kritz-Silverstein; Elizabeth W Paxton; Donald C Fithian
Journal:  Clin Orthop Relat Res       Date:  2012-09-07       Impact factor: 4.176

5.  Development of computer-tailored education program for patients with total hip replacement.

Authors:  Yeo Won Jeong; Jung A Kim
Journal:  Healthc Inform Res       Date:  2014-10-31

6.  Dual-mobility implants prevent hip dislocation following hip revision in obese patients.

Authors:  Philippe Hernigou; Jean Charles Auregan; Damien Potage; François Roubineau; Charles Henri Flouzat Lachaniette; Arnaud Dubory
Journal:  Int Orthop       Date:  2016-10-20       Impact factor: 3.075

7.  Nationwide multicenter follow-up cohort study of hip arthroplasties performed for osteonecrosis of the femoral head.

Authors:  Seneki Kobayashi; Toshikazu Kubo; Yukihide Iwamoto; Wakaba Fukushima; Nobuhiko Sugano
Journal:  Int Orthop       Date:  2018-05-12       Impact factor: 3.075

8.  Surgical Risks and Costs of Care are Greater in Patients Who Are Super Obese and Undergoing THA.

Authors:  Menachem M Meller; Nader Toossi; Mark H Gonzalez; Min-Sun Son; Edmund C Lau; Norman Johanson
Journal:  Clin Orthop Relat Res       Date:  2016-08-25       Impact factor: 4.176

9.  Dual-mobility or Constrained Liners Are More Effective Than Preoperative Bariatric Surgery in Prevention of THA Dislocation.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Charles Henri Flouzat Lachaniette
Journal:  Clin Orthop Relat Res       Date:  2016-10       Impact factor: 4.176

10.  Obesity increases length of stay and direct medical costs in total hip arthroplasty.

Authors:  Hilal Maradit Kremers; Sue L Visscher; Walter K Kremers; James M Naessens; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2013-10-08       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.